Henan Taloph Pharmaceutical Stock Co.,Ltd.’s Net Profit Rose 9.6% in First Half of 2021

Henan Taloph Pharmaceutical Stock Co.,Ltd. (河南太龙药业股份有限公司) (600222.SH) reported a net profit of 28 million yuan in the first half of 2021, up 9.6% year-on-year.

Meanwhile, the company posted 751.9 million yuan in revenue, up 16.1% year-on-year.

At the end of the reporting period, it had 3.7 billion yuan in total assets and 1.8 billion yuan in total liabilities, with a liability-to-asset ratio of 50.5%.

This article was automatically produced by Caixin Automation on Sept. 1, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.